• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两种氯化林可霉素类似物对夜猴体内氯喹耐药恶性疟原虫的活性。

Activity of two chlorinated lincomycin analogues against chloroquine-resistant falciparum malaria in owl monkeys.

作者信息

Powers K G, Jacobs R L

出版信息

Antimicrob Agents Chemother. 1972 Jan;1(1):49-53. doi: 10.1128/AAC.1.1.49.

DOI:10.1128/AAC.1.1.49
PMID:4207758
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC444165/
Abstract

The chloroquine-resistant Oak Knoll strain of Plasmodium falciparum, recently adapted to the owl monkey (Aotus trivirgatus), was insusceptible to chloroquine therapy. Two chlorinated lincomycin analogues tested in this host-parasite system cured blood-induced infections. Acute infections were treated orally for 7 consecutive days with either 15 or 75 mg of clindamycin hydrochloride (U-21) per kg per day, 10 or 50 mg of N-demethyl-4'-pentyl clindamycin hydrochloride (U-24) per kg per day, or 20 mg of chloroquine base per kg per day. These lincomycin analogues cleared trophozoites from the peripheral blood by the end of the 7-day treatment period. The speed of clearance of parasites was not dose-related, but curative activity appeared dependent upon the amount of drug given as well as the number of daily treatments. The efficacy of U-21 and U-24 is of particular interest since they represent major structural departures from compounds commonly used in the treatment of malaria.

摘要

对氯喹耐药的恶性疟原虫奥克诺尔株最近适应了夜猴(三带犰狳),对氯喹治疗不敏感。在这个宿主-寄生虫系统中测试的两种氯化林可霉素类似物治愈了血液感染。急性感染连续7天口服治疗,每天每公斤体重给予15或75毫克盐酸克林霉素(U-21)、10或50毫克盐酸N-去甲基-4'-戊基克林霉素(U-24)或20毫克氯喹碱。这些林可霉素类似物在7天治疗期结束时清除了外周血中的滋养体。寄生虫清除速度与剂量无关,但治愈活性似乎取决于给药量以及每日治疗次数。U-21和U-24的疗效特别令人感兴趣,因为它们与常用于治疗疟疾的化合物在结构上有很大差异。

相似文献

1
Activity of two chlorinated lincomycin analogues against chloroquine-resistant falciparum malaria in owl monkeys.两种氯化林可霉素类似物对夜猴体内氯喹耐药恶性疟原虫的活性。
Antimicrob Agents Chemother. 1972 Jan;1(1):49-53. doi: 10.1128/AAC.1.1.49.
2
Studies on the 2,4-diamino-6-substituted quinazolines. II. Activities of selected derivatives against infections with various drug-susceptible and drug-resistant strains of Plasmodium falciparum and Plasmodium vivax in owl monkeys.2,4-二氨基-6-取代喹唑啉的研究。II. 所选衍生物对枭猴体内各种药物敏感及耐药恶性疟原虫和间日疟原虫感染的活性。
Am J Trop Med Hyg. 1979 Sep;28(5):793-807.
3
Plasmodium falciparum and Plasmodium vivax infections in the owl monkey (Aotus trivirgatus). II. Responses to chloroquine, quinine, and pyrimethamine.猫头鹰猴(三带夜猴)体内的恶性疟原虫和间日疟原虫感染。II. 对氯喹、奎宁和乙胺嘧啶的反应
Am J Trop Med Hyg. 1978 Jul;27(4):703-17. doi: 10.4269/ajtmh.1978.27.703.
4
Effective treatment with a tetrandrine/chloroquine combination for chloroquine-resistant falciparum malaria in Aotus monkeys.采用汉防己甲素/氯喹联合疗法治疗对氯喹有抗药性的疟原虫感染的食蟹猴。
Malar J. 2013 Apr 2;12:117. doi: 10.1186/1475-2875-12-117.
5
Plasmodium falciparum and Plasmodium vivax infections in the owl monkey (Aotus trivirgatus). III. Methods employed in the search for new blood schizonticidal drugs.猫头鹰猴(三带夜猴)体内的恶性疟原虫和间日疟原虫感染。III. 寻找新型血液裂殖体杀灭药物所采用的方法。
Am J Trop Med Hyg. 1978 Jul;27(4):718-37. doi: 10.4269/ajtmh.1978.27.718.
6
In vitro and in vivo reversal of chloroquine resistance in Plasmodium falciparum with promethazine.用异丙嗪在体外和体内逆转恶性疟原虫对氯喹的耐药性。
Am J Trop Med Hyg. 1998 May;58(5):625-9. doi: 10.4269/ajtmh.1998.58.625.
7
Plasmodium falciparum in owl monkeys: drug resistance and chloroquine binding capacity.猫头鹰猴体内的恶性疟原虫:耐药性与氯喹结合能力
Science. 1970 Jul 17;169(3942):289-90. doi: 10.1126/science.169.3942.289.
8
Reversal of chloroquine resistance in malaria parasite Plasmodium falciparum by desipramine.地昔帕明逆转恶性疟原虫对氯喹的耐药性。
Science. 1988 Dec 2;242(4883):1301-3. doi: 10.1126/science.3057629.
9
Malarial infections in Aotus trivirgatus with special reference to renal pathology. II. P. falciparum and mixed malaria infections.三带犰狳的疟疾感染,特别涉及肾脏病理学。II. 恶性疟原虫和混合疟疾感染。
Br J Exp Pathol. 1975 Oct;56(5):429-38.
10
Malaria in studies in vitro. III: the protein synthesising activity of Plasmodium falciparum in vitro after drug treatment in vivo.体外研究中的疟疾。III:体内药物治疗后恶性疟原虫在体外的蛋白质合成活性。
Ann Trop Med Parasitol. 1975 Jun;69(2):135-40.

引用本文的文献

1
Probing the distinct chemosensitivity of Plasmodium vivax liver stage parasites and demonstration of 8-aminoquinoline radical cure activity in vitro.探究间日疟原虫肝脏期寄生虫的独特化学敏感性,并在体外证明 8-氨基喹啉自由基治愈活性。
Sci Rep. 2021 Oct 7;11(1):19905. doi: 10.1038/s41598-021-99152-9.
2
Anti-relapse activity of mirincamycin in the Plasmodium cynomolgi sporozoite-infected Rhesus monkey model.米林卡霉素在食蟹猴疟原虫子孢子感染的恒河猴模型中的抗复发活性。
Malar J. 2014 Oct 17;13:409. doi: 10.1186/1475-2875-13-409.
3
Efficacy of Pyrimethamine/Sulfadoxine versus Chloroquine for the Treatment of Uncomplicated Falciparum Malaria in Children Aged Under 5 Years.乙胺嘧啶/磺胺多辛与氯喹治疗5岁以下儿童单纯性恶性疟的疗效比较
Iran J Parasitol. 2013 Jan;8(1):1-17.
4
Lysis of Plasmodium falciparum by ferriprotoporphyrin IX and a chloroquine-ferriprotoporphyrin IX complex.疟原虫被高铁原卟啉IX及氯喹-高铁原卟啉IX复合物裂解。
Antimicrob Agents Chemother. 1982 May;21(5):819-22. doi: 10.1128/AAC.21.5.819.
5
Antimicrobial susceptibility of Nocardia species.诺卡菌属的抗菌药敏性。
Antimicrob Agents Chemother. 1973 Aug;4(2):85-93. doi: 10.1128/AAC.4.2.85.
6
Advances in the biology of sporozoa.孢子虫生物学的进展
Z Parasitenkd. 1974;45(2):125-62. doi: 10.1007/BF00348532.
7
Oxygen- and time-dependent effects of antibiotics and selected mitochondrial inhibitors on Plasmodium falciparum in culture.抗生素及特定线粒体抑制剂对体外培养恶性疟原虫的氧依赖性和时间依赖性效应
Antimicrob Agents Chemother. 1985 Jan;27(1):21-7. doi: 10.1128/AAC.27.1.21.
8
Falciparum malaria semi-resistant to clindamycin.对克林霉素半耐药的恶性疟
Br Med J. 1975 Apr 5;2(5961):12-4. doi: 10.1136/bmj.2.5961.12.

本文引用的文献

1
PIGMENT FORMATION AND NUCLEAR DIVISION IN CHLOROQUINE-RESISTANT MALARIA PARASITES (PLASMODIUM BERGHEI, VINCKE AND LIPS, 1948).氯喹抗性疟原虫(伯氏疟原虫,温克和利普斯,1948年)中的色素形成与核分裂
Nature. 1964 Sep 19;203:1290-1. doi: 10.1038/2031290a0.
2
Observations on two Plasmodium falciparum infections with an abnormal response to chloroquine.关于两例对氯喹有异常反应的恶性疟原虫感染的观察
Am J Trop Med Hyg. 1961 Jan;10:5-9. doi: 10.4269/ajtmh.1961.10.5.
3
Combined therapy for chloroquine-resistant, Plasmodium falciparum infection. Concurrent use of long-acting sulphormethoxine and pyrimethamine.耐氯喹恶性疟原虫感染的联合治疗。长效磺胺甲氧嗪与乙胺嘧啶联合使用。
JAMA. 1967 Jan 16;199(3):173-7.
4
Antiplasmodial activity of halogenated lincomycin analogues in Plasmodium berghei-infected mice.
Antimicrob Agents Chemother (Bethesda). 1967;7:537-42.
5
Plasmodium vinckei: production of chloroquine-resistant strain.文氏疟原虫:耐氯喹菌株的产生。
Exp Parasitol. 1969 Oct;26(2):193-202. doi: 10.1016/0014-4894(69)90112-x.
6
Lincomycin, an inhibitor of aminoacyl sRNA binding to ribosomes.林可霉素,一种抑制氨酰基sRNA与核糖体结合的抑制剂。
Proc Natl Acad Sci U S A. 1966 Feb;55(2):431-8. doi: 10.1073/pnas.55.2.431.
7
The activities of chlorinated lincomycin derivatives against infections with Plasmodium cynomolgi in Macaca mulatta.氯代林可霉素衍生物对猕猴食蟹猴疟原虫感染的活性。
Am J Trop Med Hyg. 1970 Jan;19(1):1-11. doi: 10.4269/ajtmh.1970.19.1.
8
Activity of chlorinated lincomycin analogues against Plasmodium cynomolgi in rhesus monkeys.氯代林可霉素类似物对恒河猴食蟹猴疟原虫的活性。
Am J Trop Med Hyg. 1969 Jul;18(4):485-90. doi: 10.4269/ajtmh.1969.18.485.